Marijke Fràter‐Schröder

Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.

Marijke Fràter‐Schröder, Werner Risau, Rupert Hallmann et al. · Proceedings of the National Academy of Sciences · 1987 · 711 citations · Full text

Vascular Disease, Potent Inhibitor, Endothelial Cell Growth +19

Transforming growth factor-beta inhibits endothelial cell proliferation

Marijke Fràter‐Schröder, Gertraud Müller, Walter Birchmeier et al. · Biochemical and Biophysical Research Communications · 1986 · 310 citations

Angiogenesis, Vascular Biology, Neovascularization +4

Synthesis and secretion of the human vitamin B12-binding protein, transcobalamin II, by cultured skin fibroblasts and by bone marrow cells

Marijke Fràter‐Schröder, H. J. Porck, Jale Erten et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 1985 · 33 citations

Vitamin Nutrition, Hematology, Bone Marrow Cells +7

INCREASED UNSATURATED TRANSCOBALAMIN II IN ACTIVE AUTOIMMUNE DISEASE

Marijke Fràter‐Schröder, P. J. Grob, W. H. Hitzig et al. · The Lancet · 1978 · 32 citations

Autoimmune Disease, Autoantibody Production, Immunology +5

Granulocyte dysfunction in transcobalamin II deficiency responding to leucovorin or hydroxocobalamin‐plasma transfusion

Reinhard Seger, Marijke Fràter‐Schröder, W. H. Hitzig et al. · Journal of Inherited Metabolic Disease · 1979 · 22 citations